BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Pro
Research team ‘EDC’ will study ‘Extrachromosomal DNA in Cancer’.With this project, the two partners launch their ninth collaboration, seven of which have been in the field of oncology.HEIDELBERG, Germany, August 1, 2022 / B3C newswire / -- BioMed X, a German independent research institute, announces the start o...
Source: pharmiweb.com